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Profiling the effect of nafcillin 
on HA-MRSA D712 using 
bacteriological and physiological 
media
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Richard Szubin1, Connor A. Olson1, Anne Lamsa2, Yara Seif  1, Nicholas Dillon5,6, 
Alison Vrbanac5,6, Joseph Sugie2, Samira Dahesh5,6, Jonathan M. Monk1,  
Pieter C. Dorrestein  3,4,7,8, Rob Knight  1,5,8,9, Victor Nizet  4,5,6,8,  
Bernhard O. Palsson  1,5,8,10, Adam M. Feist1,10 & Joe Pogliano2*
Staphylococcus aureus strains have been continuously evolving resistance to numerous classes of 
antibiotics including methicillin, vancomycin, daptomycin and linezolid, compounding the enormous 
healthcare and economic burden of the pathogen. Cation-adjusted Mueller-Hinton broth (CA-MHB) 
is the standard bacteriological media for measuring antibiotic susceptibility in the clinical lab, but the 
use of media that more closely mimic the physiological state of the patient, e.g. mammalian tissue 
culture media, can in certain circumstances reveal antibiotic activities that may be more predictive of 
effectiveness in vivo. In the current study, we use both types of media to explore antibiotic resistance 
phenomena in hospital-acquired USA100 lineage methicillin-resistant, vancomycin-intermediate 
Staphylococcus aureus (MRSA/VISA) strain D712 via multidimensional high throughput analysis of 
growth rates, bacterial cytological profiling, RNA sequencing, and exo-metabolomics (HPLC and 
LC-MS). Here, we share data generated from these assays to shed light on the antibiotic resistance 
behavior of MRSA/VISA D712 in both bacteriological and physiological media.
Background & Summary
Staphylococcus aureus is among the major contributors of nosocomial infection worldwide. The pathogen is 
responsible for various life-threatening diseases like pneumonia, sepsis, toxic shock syndrome, and endo-
carditis1. Over the course of time, S. aureus has sequentially developed resistance to various clinical antibiot-
ics including penicillin, methicillin, aminoglycosides, fluoroquinolones and many more2. An alarming recent 
problem is potential resistance to vancomycin, which emerged in association with hospitalization, prolonged 
infection, and extended vancomycin treatment. Commonly, methicillin-resistant Staphylococcus aureus 
(MRSA) are treated with vancomycin, which can predispose to stepwise increases in resistance progressing from 
vancomycin-intermediate (VISA) strains and ultimately strains became completely resistant to vancomycin 
(VRSA). VISA is thought to be epigenetic and triggered by prolonged exposure to even non-glycopeptide classes 
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of antibiotics like beta-lactams2,3, and currently VISA strains are much more frequent in the clinical setting than 
VRSA strains. In the present study, we focus on hospital acquired USA100 lineage VISA strain D712, previously 
collected from a patient in late phase of vancomycin and daptomycin treatment4.
Cation-adjusted Mueller-Hinton broth (CA-MHB) is the standard media used to test the quantitative suscep-
tibility of antimicrobial agents in clinical microbiology laboratories around the world. CA-MHB contains low 
thymidine and thymine while enriched in calcium and magnesium salts, and allows reproducible measurement 
of minimal inhibitory concentration (MIC) against diverse clinically-relevant bacterial species5. Recent research 
has shown that the media more closely mimic physiological conditions in the human patient, for example the 
common mammalian tissue culture media Roswell Park Memorial Institute 1640 (1640) might reveal useful 
antibiotic activities missed in CA-MHB6,7.
In the present study, we focused on elucidating the effect of nafcillin on VISA strain D712 in both bacte-
riological (CA-MHB) and physiological media (RPMI supplemented with 10% Luria broth to achieve grow 
equivalence). Between these two media the MIC value decreased from 256 µg/ml in CA-MHB to 1 µg/ml in 
RPMI + 10%LB. The effect of nafcillin at various sub-inhibitory concentrations were monitored using growth 
curves, bacterial cytological profiling (BCP), RNA sequencing, and exo-metabolomics (HPLC and LC-MS) high 
throughput experiments. The BCP assay was done to identify cytological parameters that change in response to 
antibiotic treatment RNAseq and metabolomics were used to measure changes in gene expression and secreted 
metabolites in response to the presence of nafcillin.
Methods
The methods are adapted from our previously published paper8.
Culture and growth conditions. Standard bacteriological media MHB (Sigma-Aldrich) was supplemented 
with 25 mg/L Ca2+ and 12.5 mg/L Mg2+ (CA-MHB). Eukaryotic cell culture media Roswell Park Memorial 
Institute 1640 (RPMI) (Thermo Fisher Scientific) was supplemented with 10% LB (R10LB). Broth microdilution 
was performed to determine the nafcillin MIC in each media condition. On the day of the experiment, overnight 
cultures of HA-MRSA D712 were diluted to a starting OD600 of 0.01 into fresh media and grown at 37 °C with 
stirring to OD600 0.4. This preculture was then diluted back to OD600 0.01 into fresh media containing no drug 
or sub-inhibitory concentrations of nafcillin relative for each media type. Growth was monitored by obtaining 
OD600 readings every 45 min for 6 hr. Three biological replicates were collected for the study, each derived from 
different colony and overnight culture. The growth curve is provided as Fig. 1.
Bacterial cytological profiling. At the 3 hour mark, samples were taken for fluorescence microscopy, similar 
to previously described with modifications9–11. In brief, 8 µL cells were added to 2 µL dye mix containing 10 µg/mL 
DAPI, 2.5 µM SYTOX Green, and 60 µg/mL FM4-64 in 1x T-base. The sample was then transferred to a glass 
slide containing an agarose pad (20% media, 1.2% agarose) and imaged on an Applied Precision DV Elite epif-
luorescence microscope with a CMOS camera. The exposure times for each wavelength were as follows, TRITC/
Cy-5 = 0.025 s, FITC/FITC = 0.01 s, DAPI/DAPI = 0.015 s, and were kept constant for all images.
Deconvolved images were adjusted using FIJI (ImageJ 1.51w) and Adobe Photoshop (2015.1) to remove back-
ground in WGA and DAPI channels and to ensure that cell and DNA objects are within the highest intensity 
quartile. These images were then processed using a custom CellProfiler 3.0 pipeline that individually threshold 
and filtered WGA and DAPI channels to obtain segmentation masks for the cell wall, DNA and entire cell. Objects 
identified in this manner were further processed in CellProfiler to obtain a total of 5285 features12,13. Prior to 
analysis, feature selection is necessary to create a subset of relevant features as to minimize redundancy within the 
dataset. The summary of processing steps is presented in Fig. 2.
cDNA library preparation and RNA sequencing. After 3 hours of growth, 3 mL samples were taken 
for RNA sequencing and added to tubes containing 6 mL RNAprotect. After incubation, they were centrifuged 
to remove the supernatant. RNA was extracted from the pelleted cells using a ‘Quick RNA Fungal/Bacterial 
Microprep’ kit developed by Zymo Research. The cells were mechanically lysed with a Roche MagNa Lyser 
Fig. 1 Growth curve for Staphylococcus aureus D712 strain in presence of nafcillin at various sub-inhibitory 
concentrations in CA-MHB and R10LB media.
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instrument and DNA was removed with DNase I during the RNA purification. RNA quality was checked with an 
Agilent Bioanalyzer instrument and ribosomal RNA was removed using an Illumina Ribo-Zero kit. The remain-
ing RNA was used to build a cDNA library for sequencing using a KAPA Stranded RNA-seq Library Preparation 
Kit. The kit was used for RNA fragmentation, sequencing adapter ligation, and library amplification. The gener-
ated cDNA libraries were sent for Illumina sequencing on a HiSeq. 4000.
RNA sequencing analysis. The reference genome S. aureus D712 was submitted in NCBI with accession 
number VFJD01000001.1. The genome coverage of reference genome S. aureus D712 is 60X with final genome 
size is 2,825,989 bp. D712 is an evolved strain of D592. Both D592 and D712 strains were collected from the same 
patient upon pre-daptomycin treatment and after daptomycin treatment, respectively.
The phred quality scores for illumina sequencing were generated using Fastqc package14. Bowtie2 was used to 
align the raw reads to D712 genome15 and to calculate alignment percentage, FastQC16. The aligned reads were 
then normalized to transcripts per million (TPM) with DESeq. 2. The ComBat module within the sva package of 
R was used to correct for batch effects17,18. Distance matrix for hierarchical clustering were calculated with sklearn 
package19. The summary steps are provided in Fig. 2.
Untargeted liquid chromatography mass spectrometry data acquisition. Following dilution of 
the preculture of HA-MRSA USA100 D712 into fresh media, approximately 400 µL of liquid media containing 
cells were collected at 45 minutes intervals (at the same time as samples for OD600 measurements) from each 
of the samples. Growth media was syringe-filtered through 0.22 µm disc filters (Millex-GV, MilliporeSigma) to 
remove cells. The filtered growth media was collected and stored at −80 °C until analysis by liquid chromatog-
raphy mass spectrometry (LC/MS). For LC/MS analysis, samples were subjected to chromatographic separation 
using an UltiMate 3000 UHPLC system (Thermo Scientific). Chromatographic separations were achieved using 
a 50 mm × 2.1 mm Kinetex 2.6 micron polar-C18 column (Phenomenex) held at a fixed temperature of 30 °C 
within an actively heated column compartment. Samples were injected onto the LC column via thermostatted 
autosampler maintained at 4 °C. For samples containing RPMI + 10% LB media the injection volume was 5 µl, 
while the injection volume was 2 µl for samples containing CA-MHB to prevent excessive oversaturation of the 
mass spectrometer detector due to the higher concentrations of many molecules in the CA-MHB media.
After injection, the sample components were eluted from the LC column into the mass spectrometer using 
a flow rate of 0.5 mL/min and the following mobile phases: Mobile phase A was LC/MS grade water with 0.1% 
Fig. 2 Diagram depicting the methodology of high throughput approaches used to profile the Staphylococcus 
aureus D712 in presence of nafcillin.
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formic acid (v/v) and mobile phase B was LC/MS grade acetonitrile with 0.1% formic acid (v/v). The LC gradient 
program was as follows: 0–1.0 min 5%B, 1.0–5.0 min 5–35%B, 5.0–5.5 min 35–100%B, 5.5–6.0 min 100%B, and 
6.0–6.5 min 100–5%B followed by 5 minutes of re-equilibration at 5%B. Mass spectrometric data was acquired 
using a Bruker Daltonics maXis Impact quadrupole-time-of-flight (qTOF) mass spectrometer equipped with 
an Apollo II electrospray ionization (ESI) source and controlled via otofControl v4.0.15 and Hystar v3.2 soft-
ware packages (Bruker Daltonics). The mass accuracy of the maXis instrument was first externally calibrated 
using a calibration solution of sodium formate which provided >21 reference m/z’s between 50–1500 m/z of the 
mass spectrum in both positive and negative polarities (reference m/z list provided within instrument control 
software). Sodium formate solution was prepared using 9.9 ml of 50/50% isopropanol/water, plus 0.2% formic 
acid, and 100 μl of 1 M NaOH. During infusion of all samples, the mass accuracy of the instrument was main-
tained to <10 ppm via constant introduction of and internal calibrant, or “lock mass”, in the form of hexakis 
(1 H,1 H,2H-difluoroethoxy)phosphazene (SynQuest Labs, Inc.). During positive polarity runs the lock mass 
compound was detected as the ion m/z 622.028960 (C12H19F12N3O6P3+) and in negative polarity the lock 
mass compound formed the ion m/z 556.001951 (C10H15F10N3O6P3−).
Instrument source parameters were set as follows: nebulizer gas (Nitrogen) pressure, 2 Bar; Capillary voltage, 
3,500 V; ion source temperature, 200 °C; dry gas flow, 9 L/min. The global mass spectral acquisition rate was set at 
3 Hz. The instrument transfer optics were tuned as follows: Ion funnel 1 & 2 RFs of 250 Vpp (volts peak-to-peak), 
hexapole RF of 100 Vpp, quadrupole ion energy of 5 eV, collision quadrupole energy of 5 eV, and a TOF pre-pulse 
storage of 7.0 µsecs. The post-collision quadrupole RF and TOF transfer time were stepped across four values 
per MS scan. The collision RF was stepped at 450, 550, 800, 1100 Vpp. The transfer time was stepped at 70, 75, 
90, 95 µsecs. All samples were run twice, once under positive polarity settings and once under negative polarity 
settings.
Following acquisition of the LC/MS data, lock mass calibration was applied to all data files in order to apply 
a linear correction calibration to all m/z values recorded in each mass spectrum. The application of this mass 
correction was applied automatically via the Bruker Daltonics Compass Data Analysis software (ver. 4.3.110), 
using the m/z of the hexakis (1 H,1 H,2H-difluoroethoxy) phosphazene as the reference lock mass calibration 
compound. Following lock mass re-calibration of the data, all files were converted from the Bruker Daltonics 
proprietary format (.d) and exported to an open data format known as.mzXML. All data herein was deposited to 
MassIVE20. The brief methodology is provided in Fig. 2.
targeted high-performance liquid chromatography. For organic acid and carbohydrate detection, 
samples were collected every 45 minutes and filtered as described above. The filtered samples were loaded onto 
a 1260 Infinity series (Agilent Technologies) high-performance liquid chromatography (HPLC) system with an 
Aminex HPX-87H column (Bio-Rad Laboratories) and a refractive index detector. The system was operated 
using ChemStation software. The HPLC was run with a single mobile phase composed of HPLC grade water 
buffered with 5 mM sulfuric acid (H2SO4). The flow rate was held at 0.5 mL/minute, the sample injection volume 
was 10 uL, and the column temperature was maintained at 45 °C. The identities of compounds were determined 
by retention time comparison to standard curves of acetate, ethanol, glucose, lactate, pyruvate, and succinate. The 
peak area integration and resulting chromatograms were generated within ChemStation and compared to that of 
the standard curves in order to determine the concentration of each compound in the samples. These final con-
centration values were deposited to MassIVE database20. The procedure of HPLC is depicted in Fig. 2.
exclusion criteria. The data of 0.25 ug/ml nafcillin on R10LB has been excluded from all studies due to 
the lack of statistically significant changes in presence of antibiotics (batch effect). The data and its result can be 
accessed in public repository or available upon request.
Data Records
The reference genome S. aureus D712 was submitted in NCBI15. The growth-rate data is available on Figshare21, 
while BCP, HPLC, and Mass spectrometry data have been deposited on MassIVE repository20. Complete RNAseq 
pipeline can be found at Figshare22, Fastq files of each run has been deposited on NCBI- Sequence Read Archive23. 
More processed runs for RNAseq like TPM (batch corrected) and counts can be found on NCBI- Gene Expression 
Omnibus24. However, the overall summarized statistics of RNAseq is available on Figshare25.
technical Validation
Bacterial cytological profiling. The technical validation of BCP was done through manual screening dur-
ing the image segmentation process in CellProfiler. Accurate cell and object traces and measurements were ver-
ified manually for representative images. The cell outlines were matched with corresponding related structures 
e.g. DNA through “parent” tags. Finally, the output files for the cellular features were uploaded to MassIVE repos-
itory20. A representation of the image analysis pipeline for BCP data is provided in Fig. 3.
Untargeted liquid chromatography mass spectrometry data acquisition. For each sample the 
base peak chromatogram (BPCs) and multiple extracted ion chromatograms (EICs) were compared to evaluate 
the reproducibility of global retention time and ion intensity. The reproducibility of retention time and peak 
intensity were obtained by comparing the BPCs of each experimental triplicate. While the EICs of the molecules 
were evaluated using retention time drift and peak area of <0.1 minutes and <15% correspondingly.
RNA sequencing. The reference genome of D712 was sequenced using an Illumina Hiseq. 4000. Prior to 
assembly, the quality control steps were performed to remove unincorporated primers, adaptors, and detectable 
PCR primers. The genome was then assembled into 110 contigs using Spades v3.11 and annotated using Prokka 
v1.12. The sequencing reads shows the average Phred score of >32, which further corresponds to the base calling 
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accuracy of 99.99%. The raw fastq files were uploaded at NCBI SRA web platform23. The alignment of reads with 
the reference genome gives the alignment score of 97.68%.
As the number of samples were large so their processing was done in three different batches. Further, the batch 
effect of samples in each batch were corrected using ComBat module of SVA package in R, which resulted in 
high quality downstream data with Spearman’s correlation coefficient >0.95 among all biological replicates. The 
RNAseq results are shown in Fig. 4.
Code availability
The complete RNAseq pipeline used in analysis of RNAseq data is available on Figshare22. The script to remove 
batch effects from RNAseq data is also available of Figshare26.
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